Allspring Global Investments
CGEM icon

Allspring Global Investments’s Cullinan Oncology CGEM Stock Holding History

Allspring Global Investments’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,095
Closed -$64.2K – 2306
2023
Q3 		$64.2K Sell
7,095
-11,375
-62% -$118K ﹤0.01% 2176
2023
Q2 		$199K Buy
18,470
+4,394
+31% +$46.7K ﹤0.01% 1811
2023
Q1 		$144K Buy
14,076
+5,525
+65% +$60.9K ﹤0.01% 1915
2022
Q4 		$90.2K Sell
8,551
-214
-2% -$2.6K ﹤0.01% 2112
2022
Q3 		$112K Sell
8,765
-995
-10% -$13.4K ﹤0.01% 2037
2022
Q2 		$125K Buy
9,760
+168
+2% +$1.91K ﹤0.01% 1980
2022
Q1 		$100K Sell
9,592
-1,204
-11% -$16.3K ﹤0.01% 2748
2021
Q4 		$166K Buy
+10,796
New +$215K ﹤0.01% 2669

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Allspring Global Investments's CGEM Position: Q4 2023 in Review

Allspring Global Investments sold out of Cullinan Oncology (CGEM) in Q4 2023, closing a stake of 7,095 shares — an estimated $64.2K sold.

Allspring Global Investments first reported a position in CGEM in Q4 2021 and held it in 8 quarters. The position peaked at $199K in Q2 2023. 113 funds tracked by Wall St. Rank hold CGEM as of Q4 2023.

  • Allspring Global Investments reported no remaining Cullinan Oncology position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 7,095 Cullinan Oncology shares in Q4 2023, an estimated $64.2K.
  • Allspring Global Investments first reported a position in Cullinan Oncology in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Cullinan Oncology position peaked at $199K in Q2 2023.
  • 113 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.